Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone
Abstract
Atypical antipsychotics interfere with central and peripheral neurotransmitter systems and with hormonal production. In this study we compared the effect of olanzapine and risperidone on hormonal state and sexual function (by using the Questionnaire for Sexual Dysfunction, QSD) in 40 patients with a first episode psychosis. Results were compared to those of 34 healthy controls. Patients using risperidone had significant higher prolactin levels than patients using olanzapine. Patients using olanzapine had significantly higher 17beta-estradiol levels than patients using risperidone. Overall satisfaction with sexuality was less in patients compared to controls, but not different between patients using olanzapine and those using risperidone. Problems with sexual arousal were significantly higher in patients using olanzapine compared to patients using risperidone. A significantly higher frequency of problems with ejaculation and problems with insensibility of genitals were found in patients compared to healthy controls. We found no relation between medication, prolactin and 17beta-estradiol levels, frequency of sexual activity, overall satisfaction with sexuality and any of the 18 sexual dysfunctions we investigated. Our results suggests that sexual dysfunction in patients with first episode psychosis might occur despite normal prolactin levels. Also, sexual dysfunction is highly prevalent in healthy controls. Awareness should be raised of potential sexual problems in young adults.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Only few studies have directly compared the sexual functioning associated with different atypical antipsychotics.
“To date, only few studies (534-547) have directly compared the sexual functioning associated with different atypical AP.”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [535]
Cites
Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics
Woods, S. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0607 · Cited by 2,056 · see citing works
Williams, R. M., Wilson, J. D., & Foster, D. W. (1952) · Diabetes · doi:10.2337/diab.1.2.159 · Cited by 1,449 · see citing works
Leucht, S., Pitschel‐Walz, G., Abraham, D., & Kissling, W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00105-4 · Cited by 795 · see citing works
The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
Halbreich, U. M., Borenstein, J. E., Pearlstein, T., & Kahn, L. S. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00098-2 · Cited by 758 · see citing works
Prolactin and antipsychotic medications: mechanism of action
Petty, R. G. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00158-3 · Cited by 231 · see citing works
The Effects of Antipsychotic-Induced Hyperprolactinaemia on the Hypothalamic-Pituitary-Gonadal Axis
Smith, S. M., Wheeler, M. J., Murray, R. M., & O’Keane, V. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00002 · Cited by 202 · see citing works
What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?
Knegtering, H., van der Moolen, A. E. G. M., Castelein, S., Kluiter, H., & van den Bosch, R. J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00130-0 · Cited by 196 · see citing works
Gitlin, M. J. (1994) · PubMed · Cited by 193 · see citing works
Hormonal aspects of schizophrenias: an overview
Halbreich, U. M., & Kahn, L. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00124-5 · Cited by 111 · see citing works
Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin?
Knegtering, H., van den Bosch, R., Castelein, S., Bruggeman, R., Sytema, S., & van Os, J. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.02.008 · Cited by 91 · see citing works
Modell, W. (1963) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196341138 · Cited by 84 · see citing works
Hansen, T. E., Casey, D. E., & Hoffman, W. F. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.4.567 · Cited by 79 · see citing works
Systematic Review of Sexual Problems: Epidemiology and Methodology
Dunn, K. M., Jordan, K. P., Croft, P. R., & Assendelft, W. J. (2002) · Journal of Sex & Marital Therapy · doi:10.1080/00926230290001529 · Cited by 77 · see citing works
SELMANOFF, M. K. (1981) · Endocrinology · doi:10.1210/endo-108-5-1716 · Cited by 70 · see citing works
Fortier, P., Mottard, J., Trudel, G. A., & Even, S. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007028 · Cited by 48 · see citing works
Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia.
Lavalaye, J., Linszen, D., Booij, J., Reneman, L., Gersons, B., & van Royen, E. V. (1999) · Psychiatry Research · doi:10.1016/s0925-4927(99)00032-3 · Cited by 47 · see citing works
Self-citationNew drugs for the treatment of schizophrenic patients
Fleischhacker, W. W. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb05941.x · Cited by 40 · see citing works
Hyperprolactinemia and Male Sexual Dysfunction
Dickson, R. A., & Glazer, W. M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0210g · Cited by 25 · see citing works
Olanzapine optimal dose: Results of an open‐label multicenter study in schizophrenic patients
Ishigooka, J., Murasaki, M., Miura, S., & The Olanzapine Late‐Phase Ii Study Group (2000) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2000.00738.x · Cited by 19 · see citing works
Optimal dose of risperidone and olanzapine for patients with schizophrenia in Taiwan
Liu, C.-Y., Chiu, N., Wu, C.-K., Yuan, L.-M., Hsiao, M., & Liao, O. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200301000-00008 · Cited by 12 · see citing works
Knegtering, H., Lambers, P. A., Prakken, G., & ten Brink, C. (2000) · Acta Neuropsychiatrica · doi:10.1017/s092427080003578x · Cited by 11 · see citing works
Flagged first, then by citations
1 of the 22 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488 · see citing works
Peuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0157-3 · Cited by 350 · see citing works
The Facts About Sexual (Dys)function in Schizophrenia: An Overview of Clinically Relevant Findings
de Boer, M. K., Castelein, S., Wiersma, D., Schoevers, R. A., & Knegtering, H. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv001 · Cited by 170 · see citing works
Sexual Dysfunction in First-Episode Schizophrenia Patients
Malík, P., Kemmler, G., Hummer, M., Riecher‐Rössler, A., Kahn, R. S., & Fleischhacker, W. W. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182199bcc · Cited by 115 · see citing works
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review Part II: Antipsychotics
Torre, A. L., Conca, A., Duffy, D., Giupponi, G., Pompili, M., & Grözinger, M. (2013) · Pharmacopsychiatry · doi:10.1055/s-0033-1347177 · Cited by 107 · see citing works
Sexual dysfunction in people with prodromal or first-episode psychosis
Marques, T. R., Smith, S. M., Bonaccorso, S., Gaughran, F., Kolliakou, A., Dazzan, P., Mondelli, V., Taylor, H., Forti, M. D., McGuire, P. K., et al. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.101220 · Cited by 55 · see citing works
Nunes, L. V. A., Cogo‐Moreira, H., Razzouk, D., Nunes, S. O. V., & Mari, J. D. J. (2012) · Journal of Sex & Marital Therapy · doi:10.1080/0092623x.2011.606883 · Cited by 51 · see citing works
Binder, M. D., Detraux, J., & Peuskens, J. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.906579 · Cited by 47 · see citing works
Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
Montejo, A. L., de Alarcón, R., Prieto, N., Acosta, J. M., Buch-Vicente, B., & Montejo, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020308 · Cited by 43 · see citing works
Prolactin and Psychopathology in Schizophrenia: A Literature Review and Reappraisal
Rajkumar, R. P. (2014) · Schizophrenia Research and Treatment · doi:10.1155/2014/175360 · Cited by 41 · see citing works
Brugnoli, R., Novick, D., Haro, J. M., Rossi, A., Bortolomasi, M., Frediani, S., & Borgherini, G. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-83 · Cited by 25 · see citing works
Ciocca, G., Jannini, T. B., Ribolsi, M., Rossi, R., Niolu, C., Siracusano, A., Jannini, E. A., & Lorenzo, G. D. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.750033 · Cited by 23 · see citing works
Vickers, M. L., Choi, Y. K., Eriksson, L., Polyakova-Nelson, Y., Jokovic, Z., Parker, S., Moudgil, V., Dean, J. A., Debattista, J., & Scott, J. G. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac114 · Cited by 23 · see citing works
Mishra, A. C., & Mohanty, B. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.014 · Cited by 17 · see citing works
Nunes, L. V. A., Lacaz, F. S., Bressan, R. A., Nunes, S. O. V., & Mari, J. D. J. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12040 · Cited by 14 · see citing works
Ciocca, G., Usall, J., Dolz, M., Limoncin, E., Gravina, G. L., Carosa, E., Sánchez, B., Barajas, A., Baños, I., Huerta‐Ramos, E., et al. (2015) · Rivista di psichiatria · doi:10.1708/2040.22166 · Cited by 14 · see citing works
Hong, J., Novick, D., Brugnoli, R., Karagianis, J. L., Dossenbach, M. R. K., & Haro, J. M. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-218 · Cited by 11 · see citing works
Cacho, N. D., Vila‐Badia, R., Butjosa, A., Cuadras, D., Rubio‐Abadal, E., Montes, M. J. R. , Muñoz‐Samons, D., Dolz, M., & Usall, J. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112985 · Cited by 11 · see citing works
Sexual dysfunction and central obesity in patients with first episode psychosis
Theleritis, C. G., Bonaccorso, S., Habib, N., Stahl, D. R., Gaughran, F., Vitoratou, S., Atakan, Z., Kolliakou, A., Gardner-Sood, P., Dazzan, P., et al. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2016.11.008 · Cited by 9 · see citing works
Gonadal hormone abnormalities in young patients with first-episode schizophrenia
Hu, Q., Wang, J., Liang, J., Xiu, M., Zhang, S., & Wu, F. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae063 · Cited by 7 · see citing works
Sexual dysfunctions in drug-naive male patients with first-episode schizophrenia
Sabry, W., Taweel, M. E. S. E., & Zyada, F. (2017) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000520063.00808.3d · Cited by 7 · see citing works
Kesebir, S., TOPRAK, B., Baykaran, B., Hariri, A. G., & Bilici, M. (2014) · Nöro Psikiyatri Arşivi · doi:10.4274/npa.y6838 · Cited by 7 · see citing works
Erectile dysfunction in patients with first‐episode psychosis
Gaber, H. D., Elbeh, K., Al‐Naser, F. A. W. A., & Hosny, A. (2020) · Andrologia · doi:10.1111/and.13793 · Cited by 5 · see citing works
Sexual dysfunction in first-episode schizophrenia spectrum disorders
Luckhoff, H. K., Asmal, L., Scheffler, F., du Plessis, S. S., Chiliza, B., Smit, R., Phahladira, L., & Emsley, R. A. (2022) · Psychiatry Research Communications · doi:10.1016/j.psycom.2022.100080 · Cited by 3 · see citing works
Maasoumi, R., Rahimi, F., & Naghizadeh, S. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01863-2 · Cited by 3 · see citing works
Insufficient correctness of package inserts for psychotropic drugs in Germany
Arning, A., & Seifert, R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03430-y · Cited by 2 · see citing works
Mogollón, J., Serrano, A., Padrón-Freytez, A., Uzcátegui, E., & Baptista, T. (2012) · The European Journal of Psychiatry · doi:10.4321/s0213-61632012000400005 · Cited by 2 · see citing works
Psychosis, Antipsychotic Medication, and Sexual Dysfunctions
Hert, M. D., & Detraux, J. (2018) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-68306-5_8 · Cited by 2 · see citing works
Shettima, F. B., Wakil, M. A., Sheikh, T. L., Rabbebe, I. B., Abdulaziz, M., Jidda, S. M., & Dahiru, A. M. C. (2024) · PubMed Central · doi:10.60787/nmj-64-5-311 · Cited by 1 · see citing works
psychosisdysfunction in people with prodromal or first-episode
Howes, D., Mondelli, V., Taylor, H., Forti, M. D., McGuire, P. K., Murray, R. M., Marques, O. T. R., Bonaccorso, S., Gaughran, F., & Kolliakou, A. (2012)
Maj, M., Ïðåçèäåíò, È., Tasman, A., & Herrman, H. (2011)
Disfunzioni sessuali nei trattamenti con farmaci antipsicotici
Lombardo, L., & Rossi, R. (2017) · RIVISTA DI SESSUOLOGIA CLINICA · doi:10.3280/rsc2017-002001
Current awareness in human psychopharmacology
(2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1060
Current awareness: Pharmacoepidemiology and drug safety
(2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1847
Sexual behavior in psychiatric patients: a review
(2015) · American Journal of BioMedicine · doi:10.18081/2333-5106/015-02/378-388
SEXUAL FUNCTIONING IN SCHIZOPHRENIC AND BIPOLAR FEMALE PATIENTS
Micluția, I., Damian, L. O., & Serban, A. C. (2023) · European Conference of Psychiatry and Mental Health "Galatia" · doi:10.35630/2022/12/psy.ro.13
Prolactin monitoring for patients on antipsychotic drugs: A narrative review of clinical relevance
Kar, N., & Cook, N. (2025) · Archives of Biological Psychiatry · doi:10.25259/abp_17_2025
- Authors
- van Bruggen, M., van Amelsvoort, T., Wouters, L., Dingemans, P., de Haan, L., & Linszen, D.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- ORCID
- Wouters, Luuk
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 34
- Issue
- 7
- Pages
- 989-995
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2130316627
- Cited by
- 38
- References
- 22
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 2 · 2018: 1 · 2017: 3 · 2015: 3 · 2014: 4 · 2013: 3 · 2012: 6
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychoneuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- sexual dysfunction, first-episode psychosis, olanzapine, risperidone, atypical antipsychotics, prolactin, estradiol, sexual arousal, ejaculatory dysfunction, sexual satisfaction, hormonal changes
- MeSH terms
- Olanzapine, Benzodiazepines, Cross-Sectional Studies, Estradiol, Female, Humans, Male, Prolactin, Psychotic Disorders, Sexual Dysfunction, Physiological, Antipsychotic Agents, Case-Control Studies, Risperidone, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review